Akebia Ther Valuation
| AKBA Stock | USD 2.55 0.15 6.25% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Akebia Ther shows a prevailing Real Value of $3.41 per share. The current price of the firm is $2.55. Our model approximates the value of Akebia Ther from analyzing the firm fundamentals such as profit margin of (0.43) %, and Return On Equity of -5.53 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Akebia Ther's valuation include:
Price Book 4.1167 | Enterprise Value | Enterprise Value Ebitda 63.9451 | Price Sales 3.269 | Enterprise Value Revenue 3.5057 |
Undervalued
Today
Please note that Akebia Ther's price fluctuation is very risky at this time. Calculation of the real value of Akebia Ther is based on 3 months time horizon. Increasing Akebia Ther's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Akebia Ther is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Akebia Stock. However, Akebia Ther's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.55 | Real 3.41 | Target 5.5 | Hype 2.57 | Naive 2.84 |
The real value of Akebia Stock, also known as its intrinsic value, is the underlying worth of Akebia Ther Company, which is reflected in its stock price. It is based on Akebia Ther's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Akebia Ther's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Akebia Ther helps investors to forecast how Akebia stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Akebia Ther more accurately as focusing exclusively on Akebia Ther's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Akebia Ther's intrinsic value based on its ongoing forecasts of Akebia Ther's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Akebia Ther's closest peers. If more than one evaluation category is relevant for Akebia Ther we suggest using both methods to arrive at a better estimate.
Akebia Ther Cash |
|
Akebia Valuation Trend
Comparing Akebia Ther's enterprise value against its market capitalization is a good way to estimate the value of Akebia Ther uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Akebia Revenue by Product
Akebia Ther Total Value Analysis
Akebia Ther is presently forecasted to have valuation of 561.54 M with market capitalization of 523.63 M, debt of 3.55 M, and cash on hands of 143.89 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Akebia Ther fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
561.54 M | 523.63 M | 3.55 M | 143.89 M |
Akebia Ther Investor Information
About 29.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.33. Akebia Ther had not issued any dividends in recent years. Based on the analysis of Akebia Ther's profitability, liquidity, and operating efficiency, Akebia Ther may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter.Akebia Ther Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Akebia Ther has an asset utilization ratio of 72.59 percent. This suggests that the Company is making $0.73 for each dollar of assets. An increasing asset utilization means that Akebia Ther is more efficient with each dollar of assets it utilizes for everyday operations.Akebia Ther Ownership Allocation
Akebia Ther holds a total of 218.18 Million outstanding shares. Akebia Ther shows 4.44 percent of its outstanding shares held by insiders and 28.9 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Akebia Ther Profitability Analysis
The company reported the previous year's revenue of 160.18 M. Net Loss for the year was (69.41 M) with profit before overhead, payroll, taxes, and interest of 134.03 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Akebia Ther's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Akebia Ther and how it compares across the competition.
About Akebia Ther Valuation
The stock valuation mechanism determines Akebia Ther's current worth on a weekly basis. Our valuation model uses a comparative analysis of Akebia Ther. We calculate exposure to Akebia Ther's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Akebia Ther's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 97 M | 91.4 M | |
| Pretax Profit Margin | (0.43) | (0.45) | |
| Operating Profit Margin | (0.32) | (0.33) | |
| Net Loss | (0.43) | (0.45) | |
| Gross Profit Margin | 0.61 | 0.64 |
Akebia Ther Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 210.9 M |
Akebia Ther Current Valuation Indicators
Valuation refers to the process of determining the present value of Akebia Ther and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Akebia we look at many different elements of the entity such as Akebia's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Akebia Ther, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Akebia Ther's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Akebia Ther's worth.Complementary Tools for Akebia Stock analysis
When running Akebia Ther's price analysis, check to measure Akebia Ther's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akebia Ther is operating at the current time. Most of Akebia Ther's value examination focuses on studying past and present price action to predict the probability of Akebia Ther's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Akebia Ther's price. Additionally, you may evaluate how the addition of Akebia Ther to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |